 |
|
The Accuracy of Surrogate Decision Makers
A Systematic Review
David I. Shalowitz, AB;
Elizabeth Garrett-Mayer, PhD;
David Wendler, PhD
Arch Intern Med. 2006;166:493-497.
Background Clinicians currently rely on patient-designated and next-of-kin surrogates to make end-of-life treatment decisions for incapacitated patients. Surrogates are instructed to use the substituted judgment standard, which directs them to make the treatment decision that the patient would have made if he or she were capacitated. However, commentators have questioned the accuracy with which surrogates predict patients' treatment preferences.
Methods A systematic literature search was conducted using PubMed, the Cochrane Library, and manuscript references, to identify published studies that provide empirical data on how accurately surrogates predict patients' treatment preferences and on the efficacy of commonly proposed methods to improve surrogate accuracy. Two of us (D.I.S. and D.W.) reviewed all articles and extracted data on the hypothetical scenarios used to assess surrogate accuracy and the percentage of agreement between patients and surrogates.
Results The search identified 16 eligible studies, involving 151 hypothetical scenarios and 2595 surrogate-patient pairs, which collectively analyzed 19 526 patient-surrogate paired responses. Overall, surrogates predicted patients' treatment preferences with 68% accuracy. Neither patient designation of surrogates nor prior discussion of patients' treatment preferences improved surrogates' predictive accuracy.
Conclusions Patient-designated and next-of-kin surrogates incorrectly predict patients' end-of-life treatment preferences in one third of cases. These data undermine the claim that reliance on surrogates is justified by their ability to predict incapacitated patients' treatment preferences. Future studies should assess whether other mechanisms might predict patients' end-of-life treatment preferences more accurately. Also, they should assess whether reliance on patient-designated and next-of-kin surrogates offers patients and/or their families benefits that are independent of the accuracy of surrogates' decisions.
Author Affiliations: Department of Clinical Bioethics, National Institutes of Health, Bethesda, Md (Mr Shalowitz and Dr Wendler); and Division of Biostatistics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Md (Dr Garrett-Mayer).
RELATED ARTICLE
Physicians' Decisions to Withhold and Withdraw Life-Sustaining Treatment
Neil J. Farber, Pamela Simpson, Tabassum Salam, Virginia U. Collier, Joan Weiner, and E. Gil Boyer
Arch Intern Med. 2006;166(5):560-564.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Surrogate Decision Making: Reconciling Ethical Theory and Clinical Practice
Berger et al.
ANN INTERN MED 2008;149:48-53.
ABSTRACT
| FULL TEXT
Nurses' Conceptions of Decision Making Concerning Life-Sustaining Treatment
Silen et al.
Nurs Ethics 2008;15:160-173.
ABSTRACT
Stability and Change in Patient Preferences and Spouse Substituted Judgments Regarding Dialysis Continuation
Pruchno et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2008;63:S81-S91.
ABSTRACT
| FULL TEXT
Evidence for Improving Palliative Care at the End of Life: A Systematic Review
Lorenz et al.
ANN INTERN MED 2008;148:147-159.
ABSTRACT
| FULL TEXT
Using Video Images of Dementia in Advance Care Planning
Volandes et al.
Arch Intern Med 2007;167:828-833.
ABSTRACT
| FULL TEXT
Update in Critical Care 2006
Milbrandt et al.
Am. J. Respir. Crit. Care Med. 2007;175:638-648.
FULL TEXT
|
